1. Home
  2. LAES vs ATYR Comparison

LAES vs ATYR Comparison

Compare LAES & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAES
  • ATYR
  • Stock Information
  • Founded
  • LAES 2022
  • ATYR 2005
  • Country
  • LAES Switzerland
  • ATYR United States
  • Employees
  • LAES N/A
  • ATYR N/A
  • Industry
  • LAES Semiconductors
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LAES Technology
  • ATYR Health Care
  • Exchange
  • LAES Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • LAES 270.3M
  • ATYR 290.6M
  • IPO Year
  • LAES N/A
  • ATYR 2015
  • Fundamental
  • Price
  • LAES $2.51
  • ATYR $3.34
  • Analyst Decision
  • LAES Strong Buy
  • ATYR Strong Buy
  • Analyst Count
  • LAES 1
  • ATYR 6
  • Target Price
  • LAES $6.00
  • ATYR $18.60
  • AVG Volume (30 Days)
  • LAES 4.2M
  • ATYR 1.1M
  • Earning Date
  • LAES 05-20-2025
  • ATYR 05-07-2025
  • Dividend Yield
  • LAES N/A
  • ATYR N/A
  • EPS Growth
  • LAES N/A
  • ATYR N/A
  • EPS
  • LAES N/A
  • ATYR N/A
  • Revenue
  • LAES $10,981,000.00
  • ATYR N/A
  • Revenue This Year
  • LAES N/A
  • ATYR $551.06
  • Revenue Next Year
  • LAES N/A
  • ATYR $2,144.84
  • P/E Ratio
  • LAES N/A
  • ATYR N/A
  • Revenue Growth
  • LAES N/A
  • ATYR N/A
  • 52 Week Low
  • LAES $0.29
  • ATYR $1.42
  • 52 Week High
  • LAES $11.00
  • ATYR $4.66
  • Technical
  • Relative Strength Index (RSI)
  • LAES 48.41
  • ATYR 51.21
  • Support Level
  • LAES $2.18
  • ATYR $3.06
  • Resistance Level
  • LAES $2.90
  • ATYR $3.67
  • Average True Range (ATR)
  • LAES 0.19
  • ATYR 0.25
  • MACD
  • LAES 0.01
  • ATYR 0.01
  • Stochastic Oscillator
  • LAES 45.83
  • ATYR 46.77

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: